Found: 7
Select item for more details and to access through your institution.
Preclinical and clinical developments for combination treatment of influenza.
- Published in:
- PLoS Pathogens, 2022, v. 18, n. 5, p. 1, doi. 10.1371/journal.ppat.1010481
- By:
- Publication type:
- Article
Evaluating the fitness of PA/I38T-substituted influenza A viruses with reduced baloxavir susceptibility in a competitive mixtures ferret model.
- Published in:
- PLoS Pathogens, 2021, v. 17, n. 5, p. 1, doi. 10.1371/journal.ppat.1009527
- By:
- Publication type:
- Article
Pre-Clinical Evaluation of the Antiviral Activity of Epigalocatechin-3-Gallate, a Component of Green Tea, against Influenza A(H1N1)pdm Viruses.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 12, p. 2447, doi. 10.3390/v15122447
- By:
- Publication type:
- Article
A rapid pyrosequencing assay for the molecular detection of influenza viruses with reduced baloxavir susceptibility due to PA/I38X amino acid substitutions.
- Published in:
- Influenza & Other Respiratory Viruses, 2020, v. 14, n. 4, p. 460, doi. 10.1111/irv.12725
- By:
- Publication type:
- Article
Influenza antivirals currently in late-phase clinical trial.
- Published in:
- Influenza & Other Respiratory Viruses, 2017, v. 11, n. 3, p. 240, doi. 10.1111/irv.12446
- By:
- Publication type:
- Article
Baloxavir treatment of ferrets infected with influenza A(H1N1)pdm09 virus reduces onward transmission.
- Published in:
- PLoS Pathogens, 2020, v. 16, n. 4, p. 1, doi. 10.1371/journal.ppat.1008395
- By:
- Publication type:
- Article
Assessing the fitness of a dual-antiviral drug resistant human influenza virus in the ferret model.
- Published in:
- Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-04005-4
- By:
- Publication type:
- Article